Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104096352 | 10409635 | 2 | F | 2009 | 20160706 | 20140826 | 20160719 | EXP | FR-ASTELLAS-2014US011053 | ASTELLAS | FAUCHER J-F, MORQUIN D, REYNES J, CHIROUZE, C, ET AL.. SERIAL USE OF PENTAMIDINE AND MILTEFOSINE FOR TREATING LEISHMANIA. PARASITOLOGY INTERNATIONAL. 2016;65:444-446 | 0.00 | M | Y | 65.00000 | KG | 20160719 | CN | GB | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104096352 | 10409635 | 1 | PS | AMBISOME | AMPHOTERICIN B | 1 | Unknown | 14.6 G, TOTAL DOSE | 50740 | 14.6 | G | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104096352 | 10409635 | 1 | Visceral leishmaniasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104096352 | 10409635 | OT |
104096352 | 10409635 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104096352 | 10409635 | Deafness | |
104096352 | 10409635 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104096352 | 10409635 | 1 | 200501 | 200911 | 0 |